Fusion Family Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Fusion Family Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,775	Closed	-$630K	–	43
2023 Q2	$630K	Buy	+7,775	New	+$1.01M	0.08%	26
2021 Q2	–	Sell	-282	Closed	-$42K	–	63
2021 Q1	$42K	Sell	282 -93	-25%	-$14.8K	0.01%	55
2020 Q4	$57K	Hold	375	–	–	0.01%	48
2020 Q3	$51K	Hold	375	–	–	0.01%	48
2020 Q2	$51K	Hold	375	–	–	0.01%	49
2020 Q1	$40K	Hold	375	–	–	0.01%	60
2019 Q4	$45K	Hold	375	–	–	0.01%	64
2019 Q3	$37K	Hold	375	–	–	0.01%	72
2019 Q2	$41K	Hold	375	–	–	0.01%	79
2019 Q1	$42K	Hold	375	–	–	0.01%	69
2018 Q4	$36K	Hold	375	–	–	0.01%	123
2018 Q3	$46K	Hold	375	–	–	0.01%	119
2018 Q2	$41K	Hold	375	–	–	0.01%	138
2018 Q1	$40K	Hold	375	–	–	0.01%	124
2017 Q4	$40K	Hold	375	–	–	0.01%	142
2017 Q3	$42K	Hold	375	–	–	0.01%	95
2017 Q2	$39K	Hold	375	–	–	0.01%	134
2017 Q1	$37K	Hold	375	–	–	0.01%	132
2016 Q4	$35K	Buy	+375	New	+$34.1K	0.02%	148

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fusion Family Wealth's IBB Position: Q3 2023 in Review

Fusion Family Wealth sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 7,775 shares — an estimated $630K sold.

Fusion Family Wealth first reported a position in IBB in Q4 2016 and held it in 19 quarters. The position peaked at $630K in Q2 2023. 832 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Fusion Family Wealth reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
Fusion Family Wealth sold 7,775 iShares Biotechnology ETF shares in Q3 2023, an estimated $630K.
Fusion Family Wealth first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 19 quarters.
Fusion Family Wealth's iShares Biotechnology ETF position peaked at $630K in Q2 2023.
832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Fusion Family Wealth's 13F filing for Q3 2023, filed 24 Oct 2023.